Ganirelix acetate (or diacetate), sold under the brand names Orgalutran and Antagon among others, is an injectable competitive gonadotropin-releasing...
11 KB (855 words) - 04:14, 1 June 2024
currently licensed for use in fertility treatment are cetrorelix and ganirelix. Elagolix is indicated for the treatment of moderate to severe endometriosis...
19 KB (1,923 words) - 00:57, 21 March 2024
treatments to block natural ovulation. Abarelix Cetrorelix Degarelix Ganirelix Elagolix Linzagolixa Relugolix a = Under development; not yet marketed...
6 KB (514 words) - 19:52, 27 March 2024
Peforelin Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone...
9 KB (881 words) - 13:39, 28 July 2024
Peforelin Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone...
34 KB (3,380 words) - 21:31, 24 October 2024
Peforelin Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone...
49 KB (5,382 words) - 00:13, 1 November 2024
(August 2001). "Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatment during ovarian stimulation for conventional IVF or ICSI: a...
181 KB (20,983 words) - 20:13, 25 October 2024
Peforelin Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone...
24 KB (2,462 words) - 20:32, 3 July 2024
Peforelin Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone...
18 KB (1,655 words) - 13:19, 26 October 2024
Peforelin Triptorelin Antagonists Peptide: Abarelix Cetrorelix Degarelix Ganirelix Non-peptide: Elagolix Linzagolix† Relugolix (+estradiol/norethisterone...
11 KB (1,114 words) - 15:00, 1 October 2024